Itopride Therapy

Itopride Therapy is a pharmacological prokinetic intervention that specifically enhances gastrointestinal motility through dual inhibition of acetylcholinesterase and blockade of dopamine D2 receptors, distinguishing it from other prokinetic agents by its unique dual-mode mechanism of action.

41

Publications

1.9K

Citations

214

Authors

82

Institutions

Publications per year

2017–2026

7

Authors

214

  1. JT
    Jan Tack

    KU Leuven, Belgium

    6 publications · 369 citations

    6

    h-index

  2. LH
    Lieselot Holvoet

    KU Leuven, Belgium

    3 publications · 88 citations

    3

    h-index

  3. TV
    Tim Vanuytsel

    KU Leuven, Belgium

    3 publications · 88 citations

    3

    h-index

  4. AV
    Alain Vandenberghe

    KU Leuven, Belgium

    3 publications · 88 citations

    3

    h-index

  5. YI
    Yuji Iwanaga

    Hokuriku Electric Power Company (Japan), Japan

    3 publications · 148 citations

    3

    h-index

1–5 of 214

Venues

  1. PubMed

    Repository · 5 publications · 187 citations

    5

    h-index

  2. Neurogastroenterology & Motility

    4 publications · 149 citations

    4

    h-index

  3. 2

    h-index

  4. Alimentary Pharmacology & Therapeutics

    2 publications · 90 citations

    2

    h-index

  5. The Japanese Journal of Pharmacology

    2 publications · 96 citations

    2

    h-index

1–5